The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prescription Migraine Medicine Market Research Report 2024
Synopsis
Prescription migraine medicines are medications that require a doctor's prescription and are specifically designed to treat migraines. These medications are typically more potent and targeted in their approach to managing migraine symptoms.
Global Prescription Migraine Medicine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prescription Migraine Medicine market research.
Headaches and migraines are common conditions affecting a significant portion of the population. The increasing prevalence of these conditions drives the demand for prescription headache medicines as individuals seek effective treatment options to manage their symptoms. While over-the-counter medications can provide relief for many individuals with mild headaches, there is a substantial population that experiences moderate to severe headaches or migraines that require stronger prescription medications. The unmet medical needs of this population drive the demand for prescription headache medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Prescription Migraine Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GSK
Teva
Pfizer
Amgen
Viatris
Allergan
Grunenthal
Eli Lilly
Segment by Type
Sumatriptan
Rizatriptan
Others
Segment by Application
Hospital
Clinic
Drug Store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Prescription Migraine Medicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Prescription migraine medicines are medications that require a doctor's prescription and are specifically designed to treat migraines. These medications are typically more potent and targeted in their approach to managing migraine symptoms.
Global Prescription Migraine Medicine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prescription Migraine Medicine market research.
Headaches and migraines are common conditions affecting a significant portion of the population. The increasing prevalence of these conditions drives the demand for prescription headache medicines as individuals seek effective treatment options to manage their symptoms. While over-the-counter medications can provide relief for many individuals with mild headaches, there is a substantial population that experiences moderate to severe headaches or migraines that require stronger prescription medications. The unmet medical needs of this population drive the demand for prescription headache medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Prescription Migraine Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GSK
Teva
Pfizer
Amgen
Viatris
Allergan
Grunenthal
Eli Lilly
Segment by Type
Sumatriptan
Rizatriptan
Others
Segment by Application
Hospital
Clinic
Drug Store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Prescription Migraine Medicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prescription Migraine Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sumatriptan
1.2.3 Rizatriptan
1.2.4 Others
1.3 Market by Application
1.3.1 Global Prescription Migraine Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prescription Migraine Medicine Market Perspective (2018-2029)
2.2 Prescription Migraine Medicine Growth Trends by Region
2.2.1 Global Prescription Migraine Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prescription Migraine Medicine Historic Market Size by Region (2018-2023)
2.2.3 Prescription Migraine Medicine Forecasted Market Size by Region (2024-2029)
2.3 Prescription Migraine Medicine Market Dynamics
2.3.1 Prescription Migraine Medicine Industry Trends
2.3.2 Prescription Migraine Medicine Market Drivers
2.3.3 Prescription Migraine Medicine Market Challenges
2.3.4 Prescription Migraine Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prescription Migraine Medicine Players by Revenue
3.1.1 Global Top Prescription Migraine Medicine Players by Revenue (2018-2023)
3.1.2 Global Prescription Migraine Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Prescription Migraine Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prescription Migraine Medicine Revenue
3.4 Global Prescription Migraine Medicine Market Concentration Ratio
3.4.1 Global Prescription Migraine Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prescription Migraine Medicine Revenue in 2022
3.5 Prescription Migraine Medicine Key Players Head office and Area Served
3.6 Key Players Prescription Migraine Medicine Product Solution and Service
3.7 Date of Enter into Prescription Migraine Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prescription Migraine Medicine Breakdown Data by Type
4.1 Global Prescription Migraine Medicine Historic Market Size by Type (2018-2023)
4.2 Global Prescription Migraine Medicine Forecasted Market Size by Type (2024-2029)
5 Prescription Migraine Medicine Breakdown Data by Application
5.1 Global Prescription Migraine Medicine Historic Market Size by Application (2018-2023)
5.2 Global Prescription Migraine Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prescription Migraine Medicine Market Size (2018-2029)
6.2 North America Prescription Migraine Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Prescription Migraine Medicine Market Size by Country (2018-2023)
6.4 North America Prescription Migraine Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prescription Migraine Medicine Market Size (2018-2029)
7.2 Europe Prescription Migraine Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Prescription Migraine Medicine Market Size by Country (2018-2023)
7.4 Europe Prescription Migraine Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prescription Migraine Medicine Market Size (2018-2029)
8.2 Asia-Pacific Prescription Migraine Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Prescription Migraine Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Prescription Migraine Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prescription Migraine Medicine Market Size (2018-2029)
9.2 Latin America Prescription Migraine Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Prescription Migraine Medicine Market Size by Country (2018-2023)
9.4 Latin America Prescription Migraine Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prescription Migraine Medicine Market Size (2018-2029)
10.2 Middle East & Africa Prescription Migraine Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Prescription Migraine Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Prescription Migraine Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Prescription Migraine Medicine Introduction
11.1.4 GSK Revenue in Prescription Migraine Medicine Business (2018-2023)
11.1.5 GSK Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Prescription Migraine Medicine Introduction
11.2.4 Teva Revenue in Prescription Migraine Medicine Business (2018-2023)
11.2.5 Teva Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Prescription Migraine Medicine Introduction
11.3.4 Pfizer Revenue in Prescription Migraine Medicine Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Prescription Migraine Medicine Introduction
11.4.4 Amgen Revenue in Prescription Migraine Medicine Business (2018-2023)
11.4.5 Amgen Recent Development
11.5 Viatris
11.5.1 Viatris Company Detail
11.5.2 Viatris Business Overview
11.5.3 Viatris Prescription Migraine Medicine Introduction
11.5.4 Viatris Revenue in Prescription Migraine Medicine Business (2018-2023)
11.5.5 Viatris Recent Development
11.6 Allergan
11.6.1 Allergan Company Detail
11.6.2 Allergan Business Overview
11.6.3 Allergan Prescription Migraine Medicine Introduction
11.6.4 Allergan Revenue in Prescription Migraine Medicine Business (2018-2023)
11.6.5 Allergan Recent Development
11.7 Grunenthal
11.7.1 Grunenthal Company Detail
11.7.2 Grunenthal Business Overview
11.7.3 Grunenthal Prescription Migraine Medicine Introduction
11.7.4 Grunenthal Revenue in Prescription Migraine Medicine Business (2018-2023)
11.7.5 Grunenthal Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Prescription Migraine Medicine Introduction
11.8.4 Eli Lilly Revenue in Prescription Migraine Medicine Business (2018-2023)
11.8.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
